DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160047

Biochemical assessment of nephroprotective and nephrocurative activity of Withania somnifera on gentamicin induced nephrotoxicity in experimental rats

Vimlesh Kushwaha, Monica Sharma, Pinki Vishwakarma, Manish Saini, Kuldeep Saxena

Abstract


Background: Renal diseases are among the commonest cause of hospitalization in most of the countries. Acute renal failure (ARF) is a common and serious renal problem having high morbidity and mortality rate. So, prevention of occurrence and progression of acute renal failure (ARF) has become a very important issue. However modern system of medicine lacks reliable nephroprotective drugs. Ashwagandha (Withania somnifera), a traditional Indian plant having antioxidant property may be used for nephroprotection.

Methods: The study was carried out in two phases. In phase 1, evaluation of nephroprotection was done. 54 rats were randomised in 3 groups named G10, G20 and G30 according to 10, 20 and 30 days of treatment. In each of the main groups, rats were randomly assigned to any of the three subgroups i.e. control C group (received normal saline (2ml/100gm/day) orally once a day consecutively for test duration), gentamicin treated GT (received normal saline (2ml/100gm/day) orally once a day consecutively for test duration, Injection gentamicin (40mg/kg) was given intraperitonealy once daily for last five days) and W. Somnifera treated WST group (received W. somnifera orally (500mg/kg/day) as a single dose in morning for the test duration and injection gentamicin (40mg/kg) was given intra-peritonealy once daily for last five days). Rats were sacrificed 24 hours after the last dose of gentamicin injection (on 11th, 21st and 31st day). In Phase-2 nephrocurative activity of W. somnifera was compared with the spontaneous reversal of gentamicin induced nephrotoxicity. 72 rats were randomized into two groups. In Group-1: 36 rats received intra-peritoneal gentamicin for five days in a dose of 40 mg/kg. In Group-2: 36 rats received intra-peritoneal gentamicin for five days in a dose of 40 mg/kg. From the 5th day onward these rats received W. Somnifera orally in a dose of 500mg/kg/day till the rats are sacrificed. Six rats from each group were sacrificed on 3rd, 5th, 7th, 10th, 12th and 14th day after administration of last dose of Gentamicin. Blood sample were taken for evaluation of BUN and serum creatinine

Results: BUN and serum creatinine values were significantly low as compared to GT group in all test duration in phase-1. In phase two there was no significant difference of these markers in two groups.

Conclusions: Withania Somnifera root extract have nephroprotective activity against gentamicin induced nephrotoxicity.

 


Keywords


Nephroprotective, Nephrocurative, Withania somnifera, Gentamicin

Full Text:

PDF

References


Devasmita C, Ziauddin A. Drug associated renal dysfunction and injury. Nat Clin Pract Nephr. 2006;2(2):80-1.

Bellomo R. The epidemiology of acute renal failure: 1975 versus 2005. Curr Opin Crit Care. 2006;12(6):557-60.

Naughton CA. Drug induced nephrotoxicity. Am Fem Physician. 2008;78(6):743-50.

Lakshmi MS, Reddy UK, Rani S. A review on medicinal plant for nephroprotective activity. Asian J Pharm Clin Res. 2012;5:251.

Abdel-Zaher AO, Abdel-Hady RA, Mahmoud MM, Farrag MMY. The potential protective role of alphalipoic acid against acetaminophen- induced hepatic and renal damage. Toxicology. 2008;243:261-70.

Brinda P, Sridharan G, Pradeep V, Sasikumar S. Antitumor activity and in vivo antioxidant status of Hyptissuaveol against Ehrich ascites carcinoma in swiss albino mice. Inves New Drug. 2008;4510-4.

Lavi D, Glotter E, Shro Y. Constituents of Withania somnifera Dun, The structure of Withaferin A. Journal Chem Soc. 1965;30:7517-31.

Sharma V, Sharma S, Paliwal R. Withania somnifera: A Rejuvenating Ayurvedic Medicinal Herb for the Treatment of various Human ailments. Int J Pharm Tech Res. 2011;3(1):187-92.

Das K, Samanta TT, Samanta P, Nandi DK. Effect of extract of Withania somnifera on dehydration induced oxidative stress- related uremia in male rats. Saudi J Kidney Dis Transpl. 2010;21(1):75-80.

Zbigniew K, Przemystaw K, Morys J. General anaesthesia in rats undergoing experiments on the central nervous system. Folia Morphol. 2001;60(4):235-42.

Marshall EK. A new method for the determination of urea in blood. J Biol Chem. 1993;15:487-94.

Pardue HL. Kinetic aspects of analytical chemistry. Anal Chem Acta. 1989;216:69-107.

Ghosh MN. Fundamentals of experimental pharmacology 4th ed. Kolkata: Hilton & Company; 2008.235-7.

Luft FC, Bloch R, Sloan RS, Yum MN, Costello R, Maxwell DR. Comparative nephrotoxicity of aminoglycoside antibiotics on rats. J Infect Dis. 1978;138:541-5.

Ali BH, Al Za'abi M, Blunden G, Nemmar A. Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research. Basic Clin Pharmacol.2011;109(4):225-32.

Seale TW, Rennert OM. Mechanism of antibiotic-induced nephrotoxicity. Aim Clin Lab Sci. 1982;12:1-10.

Gyselynck AM, Forrey A, Cutler R. Pharmacokinetics of gentamicin: Distribution and plasma renal clearance. J Infect Dis. 1971;124:70-6.

Mingeot, Leclerq MP, Tulkens PM. Aminoglycosies nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003-12.

Markowitz GS, Parazella MA. Drug induced renal failure: A focus on tubulinterstitial disease. Clin Chim Acta. 2005;351:31-47.